Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      ‘You can blame us’: The firm that sparked accountancy private equity gold rush

      On the hunt for lost savings

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Overseas games: Will World Cup success force Fifa’s hand over divisive issue?

      Jubilant Liverpool FC fans in red jerseys and hats cheering at a stadium during a match

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • City AM Puzzles
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      For Albarino in the City, head to Humble Grape

      Libby Albarino holding a bottle of Zarate wine and a glass by the ocean

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper

GSK

  • GlaxoSmithKline to investigate fresh bribery claims in Syria

    August 12, 2014

    GlaxoSmithKline is facing new bribery allegations in Syria, the latest in a string of accusations flung at the drugmaker from countries across the world. The FTSE 100-quoted company is accused of bribing Syrian doctors and officials to boost sales of its medicines, by offering cash, trips and free med­ical samples. The latest claims emerged after [...]

  • RBS chairman Sir Philip Hampton mulls move to head GlaxoSmithKline

    August 8, 2014

    Sir Philip Hampton could jump ship to leading pharmaceutical firm GlaxoSmithKline after six years chair­ing RBS, it was reported yesterday. Neither is in any rush to replace its chairman – Glaxo’s chair Sir Christopher Gent expects to serve at the firm until the end of next year. He has served at the company for a [...]

  • Philip Hampton is being lined up to replace Sir Christopher Gent as GSK’s next chairman

    August 7, 2014

    Sir Philip Hampton is being lined up to take the role of chairman at Britain’s biggest drug company Glaxosmithkline after exiting Royal Bank of Scotland, Sky News reports. It’s said that Hampton will join GSK as early as next month as a non-executive director or deputy chairman, moving into the chairman’s seat by 2015. GSK’s [...]

  • GSK says separate consumer business is possible

    July 27, 2014

    The chief executive of GlaxoSmithKline has said that he is open to the idea of creating a breakaway consumer healthcare business, the FT reports.   Sir Andrew Witty said that a breakup of the group would be reasonable if a time came when a standalone consumer business offered more value.   He said that his [...]

  • GSK seeks regulatory approval for the first ever malaria vaccine

    July 24, 2014

    British drugmaker GlaxoSmithKline (GSK) has developed the world's first anti-malaria vaccine, designed for use on children in Africa.   If GSK acquires the regulatory approval it is currently seeking, it will mark a big step forward in the fight against the mosquito-borne parasitic disease, which currently kills over 600,000 people a year.   Most of [...]

  • GSK cuts profit outlook as lung drug sales slow

    July 23, 2014

    GLAXOSMITHKLINE (GSK) cut its full-year outlook yesterday after posting a 13 per cent decline in second-quarter sales, as it struggled to maintain its position in the significant lung drug market. The FTSE 100-listed pharmaceuticals giant posted a 25 per cent slump in core operating profit to £1.4bn in the second quarter, while turnover fell 13 [...]

  • London Report: Tesco share price falls to lowest in 10 years as GSK warns on earnings

    July 23, 2014

    Shares in Tesco yesterday fell to their lowest level in almost a decade after the beleaguered super­market issued a profit warning earlier this week and announced that chief executive Philip Clarke is stepping down. Tesco’s shares fell 0.49 per cent to 276p yesterday, down 4.6 per cent since Monday when Clarke’s exit was announced and [...]

  • GlaxoSmithKline share price plunges following a 14pc fall in profits

    July 23, 2014

    No respite for GlaxoSmithKline. Shares in the pharmaceutical giant took a drubbing today, plummeting as much as 6.9 per cent after the drugmaker posted a 14 per cent fall in second quarter profits. Shares recovered slightly, closing down around five per cent.  One of its key drugs, Avadir, a treatment for asthma, makes up around [...]

  • GlaxoSmithKline China: Company admits to bribery scandal in 2001

    July 17, 2014

    GlaxoSmithKline (GSK) has admitted that members of its staff were caught bribing Chinese officials back in 2001, according to the Financial Times. The new information has emerged as the pharmaceutical giant faces intense scrutiny from authorities in the UK and US regarding the alleged bribing of doctors and officials to boost drug sales to China. [...]

  • GlaxoSmithKline China bribery claims: British man charged

    July 14, 2014

    A British corporate investigator and his wife have been formally charged by Chinese authorities with illegally obtaining private information, in a case linked to the GlazoSmithKline (GSK) bribery claims.  Peter Humphrey and his wife Yu Ying Zeng, an American citizen, were arrested in August 2013 over claims they "illegally trafficked a huge amount of personal information on Chinese [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Next

Trending Articles

  • Big Four’s AIM exodus accelerates as mid-tier firms seize mandates

  • EY and London managing partner fined over £1.3m for audit failure

  • FTSE 100 firm agrees £5.7bn takeover in latest private equity swoop

  • Burnham backs plan to pump £1bn pension funds into start-ups

  • As it happened: Stocks jump as oil drops; Unilever shares soar on decade-best sales

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited